vs
Ares Commercial Real Estate Corp（ACRE）与Assertio Holdings, Inc.（ASRT）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是Ares Commercial Real Estate Corp的1.0倍（$13.5M vs $13.2M），Ares Commercial Real Estate Corp同比增速更快（-24.5% vs -57.9%），过去两年Ares Commercial Real Estate Corp的营收复合增速更高（-15.9% vs -35.4%）
Ares Commercial Real Estate Corp是隶属于阿瑞斯管理集团的专业金融企业，专注于商业地产领域，提供优先抵押贷款、次级债务、优先股投资等各类定制化融资解决方案，主要服务覆盖美国全境的中型商业地产所有者及运营主体。
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
ACRE vs ASRT — 直观对比
营收规模更大
ASRT
是对方的1.0倍
$13.2M
营收增速更快
ACRE
高出33.4%
-57.9%
两年增速更快
ACRE
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.2M | $13.5M |
| 净利润 | $-3.9M | — |
| 毛利率 | — | — |
| 营业利润率 | -29.2% | -86.7% |
| 净利率 | -29.2% | — |
| 营收同比 | -24.5% | -57.9% |
| 净利润同比 | 63.8% | — |
| 每股收益（稀释后） | — | $-4.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACREASRT
| Q4 25 | $13.2M | $13.5M | ||
| Q3 25 | $14.1M | $49.5M | ||
| Q2 25 | $12.6M | $29.2M | ||
| Q1 25 | $14.9M | $26.5M | ||
| Q4 24 | $17.5M | $32.2M | ||
| Q3 24 | $16.7M | $29.2M | ||
| Q2 24 | $16.8M | $31.1M | ||
| Q1 24 | $18.7M | $32.4M |
净利润ACREASRT
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $4.7M | $11.4M | ||
| Q2 25 | $-11.0M | $-16.4M | ||
| Q1 25 | $9.3M | $-13.5M | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-5.9M | $-2.9M | ||
| Q2 24 | $-6.1M | $-3.7M | ||
| Q1 24 | $-12.3M | $-4.5M |
营业利润率ACREASRT
| Q4 25 | -29.2% | -86.7% | ||
| Q3 25 | 33.0% | 23.2% | ||
| Q2 25 | -87.8% | -27.5% | ||
| Q1 25 | 64.4% | -50.0% | ||
| Q4 24 | -61.0% | -41.9% | ||
| Q3 24 | -35.3% | -10.4% | ||
| Q2 24 | -36.5% | -11.6% | ||
| Q1 24 | -65.9% | -13.4% |
净利率ACREASRT
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | 23.1% | ||
| Q2 25 | -87.8% | -56.0% | ||
| Q1 25 | 62.5% | -51.1% | ||
| Q4 24 | -60.9% | — | ||
| Q3 24 | -35.3% | -10.0% | ||
| Q2 24 | -36.5% | -11.8% | ||
| Q1 24 | -65.9% | -13.9% |
每股收益（稀释后）ACREASRT
| Q4 25 | — | $-4.54 | ||
| Q3 25 | — | $0.11 | ||
| Q2 25 | — | $-0.17 | ||
| Q1 25 | — | $-0.14 | ||
| Q4 24 | — | $-3.28 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.3M | $63.4M |
| 总债务越低越好 | $948.2M | — |
| 股东权益账面价值 | $509.6M | $94.0M |
| 总资产 | $1.6B | $267.0M |
| 负债/权益比越低杠杆越低 | 1.86× | — |
8季度趋势，按日历期对齐
现金及短期投资ACREASRT
| Q4 25 | $29.3M | $63.4M | ||
| Q3 25 | $84.9M | $93.4M | ||
| Q2 25 | $90.0M | $98.2M | ||
| Q1 25 | $125.5M | $87.3M | ||
| Q4 24 | $63.8M | $100.1M | ||
| Q3 24 | $68.9M | $88.6M | ||
| Q2 24 | $70.6M | $88.4M | ||
| Q1 24 | $99.5M | $80.7M |
总债务ACREASRT
| Q4 25 | $948.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $718.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $38.6M |
股东权益ACREASRT
| Q4 25 | $509.6M | $94.0M | ||
| Q3 25 | $521.0M | $105.8M | ||
| Q2 25 | $523.7M | $93.3M | ||
| Q1 25 | $542.1M | $108.5M | ||
| Q4 24 | $540.1M | $121.1M | ||
| Q3 24 | $563.8M | $130.5M | ||
| Q2 24 | $582.3M | $132.2M | ||
| Q1 24 | $601.1M | $134.5M |
总资产ACREASRT
| Q4 25 | $1.6B | $267.0M | ||
| Q3 25 | $1.4B | $319.8M | ||
| Q2 25 | $1.4B | $273.8M | ||
| Q1 25 | $1.5B | $286.4M | ||
| Q4 24 | $1.8B | $284.7M | ||
| Q3 24 | $1.9B | $276.0M | ||
| Q2 24 | $2.1B | $279.4M | ||
| Q1 24 | $2.1B | $282.0M |
负债/权益比ACREASRT
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.4M | $-30.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACREASRT
| Q4 25 | $21.4M | $-30.0M | ||
| Q3 25 | $3.8M | $-4.8M | ||
| Q2 25 | $4.9M | $19.1M | ||
| Q1 25 | $8.0M | $-12.5M | ||
| Q4 24 | $35.5M | $11.5M | ||
| Q3 24 | $8.4M | $-35.0K | ||
| Q2 24 | $8.7M | $7.4M | ||
| Q1 24 | $11.4M | $7.5M |
资本支出强度ACREASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ACREASRT
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | -0.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACRE
暂无分部数据
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
